The magic bullet: Niclosamide

The magic bullet: Niclosamide

The term ‘magic bullet’ is a scientific concept proposed by the German Nobel laureate Paul Ehrlich in 1907, describing a medicine that could specifically and efficiently target a disease without harming the body. Oncologists have been looking for a magic bullet for cancer therapy ever since. However...

Full description

Bibliographic Details
Main Authors:	Haowen Jiang, Albert M. Li, Jiangbin Ye
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	niclosamide mitochondrial uncoupler metabolism epigenetics anti-tumor effect oncogenic pathways
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1004978/full

Similar Items

Structural investigations on the mitochondrial uncouplers niclosamide and FCCP
by: Ng, Mei Ying, et al.
Published: (2024)

Nitro-Deficient Niclosamide Confers Reduced Genotoxicity and Retains Mitochondrial Uncoupling Activity for Cancer Therapy
by: Tsz Wai Ngai, et al.
Published: (2021-09-01)

Niclosamide in prostate cancer: An inhibitor of AR-V7, a mitochondrial uncoupler, or more?
by: Minas Sakellakis
Published: (2023-01-01)

Sublethal effects of niclosamide on the aquatic snail Pomacea canaliculata
by: Chunping Yang, et al.
Published: (2023-07-01)

Pharmacokinetic considerations for enhancing drug repurposing opportunities of anthelmintics: Niclosamide as a case study
by: Jeong In Seo, et al.
Published: (2024-04-01)

Niclosamide is a potential candidate for the treatment of chemo-resistant osteosarcoma
by: Xiaoling Huang, et al.
Published: (2023-02-01)

The PINK1 Activator Niclosamide Mitigates Mitochondrial Dysfunction and Thermal Hypersensitivity in a Paclitaxel-Induced <i>Drosophila</i> Model of Peripheral Neuropathy
by: Hye-Ji Jang, et al.
Published: (2022-04-01)

Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway
by: Liang-Tsai Yeh, et al.
Published: (2022-01-01)

Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells
by: Thanaporn Kulthawatsiri, et al.
Published: (2023-11-01)

Efficacy of niclosamide as a potential antipenetrant (TAP) against cercariae of Schistosoma mansoni monkeys
by: John I. Bruce, et al.
Published: (1992-01-01)

Niclosamide Attenuates Inflammation-Associated Profibrotic Responses in Human Subepithelial Lung Myofibroblasts
by: Michail Spathakis, et al.
Published: (2023-07-01)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
by: Hee Eun Kang, et al.
Published: (2021-07-01)

Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes
by: Hanaa Wanas, et al.
Published: (2023-05-01)

Study on the Synergistic Molluscicidal Effect of Pedunsaponin A and Niclosamide
by: Chunping Yang, et al.
Published: (2022-11-01)

Low doses of niclosamide and quinacrine combination yields synergistic effect in melanoma via activating autophagy-mediated p53-dependent apoptosis
by: Xuan Zheng, et al.
Published: (2022-07-01)

Synthesis and Clinical Examination of Novel Formulations of Ivermectin, Albendazole and Niclosamide for the Treatment of Equine Gastrointestinal Helminthoses
by: Victor Alevichxee Marchenko, et al.
Published: (2023-03-01)

The Impact of Niclosamide Exposure on the Activity of Antioxidant Enzymes and the Expression of Glucose and Lipid Metabolism Genes in Black Carp (<i>Mylopharyngodon piceus</i>)
by: Hao Wu, et al.
Published: (2023-12-01)

Niclosamide alleviates pathological angiogenesis in hepatopulmonary syndrome by inhibiting
by: LI Caiyi, et al.
Published: (2023-06-01)

Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer
by: Linjuan Huang, et al.
Published: (2023-07-01)

Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo
by: Sze-Kwan Lam, et al.
Published: (2022-10-01)

Protective Effect of Niclosamide on Lipopolysaccharide-induced Sepsis in Mice by Modulating STAT3 Pathway
by: Se Gwang JANG
Published: (2023-12-01)

Presumed veterinary niclosamide-induced retinal toxicity in a human: a case report
by: Fatemeh Bazvand, et al.
Published: (2023-03-01)

Niclosamide exposure disrupts antioxidant defense, histology, and the liver and gut transcriptome of Chinese soft-shelled turtle (Pelodiscus sinensis)
by: Jing Xiang, et al.
Published: (2023-07-01)

Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma
by: Syue-Wei Peng, et al.
Published: (2023-02-01)

Exploring Structure–Activity Relationships of Niclosamide-Based Colistin Potentiators in Colistin-Resistant Gram-Negative Bacteria
by: Liam Berry, et al.
Published: (2024-01-01)

Niclosamide Modulates the Cellular and Humoral Immune Response in Balb/c Mice
by: Bilal Mahmood Beg, et al.
Published: (2022-12-01)

Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
by: Xiaolin Pei, et al.
Published: (2022-01-01)

Hydrotalcite–Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections
by: Goeun Choi, et al.
Published: (2021-05-01)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
by: Young Yi, et al.
Published: (2021-09-01)

In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment
by: Jesse W. Wotring, et al.
Published: (2022-08-01)

The molluscicidal activity of niclosamide (Bayluscide WP70®) on Melanoides tuberculata (Thiaridae), a snail associated with habitats of Biomphalaria glabrata (Planorbidae)
by: Alexandre Giovanelli, et al.
Published: (2002-07-01)

Amorphous Solid Dispersions and the Contribution of Nanoparticles to In Vitro Dissolution and In Vivo Testing: Niclosamide as a Case Study
by: Miguel O. Jara, et al.
Published: (2021-01-01)

Bovine Serum Albumin-Coated Niclosamide-Zein Nanoparticles as Potential Injectable Medicine against COVID-19
by: Sanoj Rejinold N, et al.
Published: (2021-07-01)

Niclosamide as a Promising Therapeutic Player in Human Cancer and Other Diseases
by: Zhan Wang, et al.
Published: (2022-12-01)

Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug
by: Junyi Ren, et al.
Published: (2022-11-01)

Niclosamide from an anthelmintic drug to a promising adjuvant therapy for diabetic kidney disease: randomized clinical trial
by: Basma Mahrous El-fatatry, et al.
Published: (2023-02-01)

Niclosamide Triggers Non-Canonical LC3 Lipidation
by: Yajun Liu, et al.
Published: (2019-03-01)

A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities
by: Youlin Deng, et al.
Published: (2016-08-01)

Repurposing Niclosamide as a Therapeutic Drug against Acute Liver Failure by Suppressing Ferroptosis
by: Xiao Zhong, et al.
Published: (2023-07-01)

3D-Printed Gastroretentive Tablets Loaded with Niclosamide Nanocrystals by the Melting Solidification Printing Process (MESO-PP)
by: Juan Pablo Real, et al.
Published: (2023-04-01)